{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T23:04:53Z","timestamp":1648681493858},"reference-count":5,"publisher":"Informa Healthcare","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1517\/14740338.6.5.475","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T12:10:51Z","timestamp":1190117451000},"page":"475-476","source":"Crossref","is-referenced-by-count":0,"title":["The safety of obesity drugs \u2013 correspondence"],"prefix":"10.1517","volume":"6","author":[{"given":"Luc F","family":"Van Gaal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 J","family":"Scheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Formiguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2007,9,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.6.1083"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66374-X"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044537"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.7.761"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69571-8"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.6.5.475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T09:08:04Z","timestamp":1481620084000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.6.5.475"}},"subtitle":["Response to: GREENWAY FL, CARUSO MK: Safety of obesity drugs.<i>Expert Opin. Drug Saf.<\/i>(2005)<b>4<\/b>(6):1083-1095."],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":5,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,9,18]]},"published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1517\/14740338.6.5.475"],"URL":"https:\/\/doi.org\/10.1517\/14740338.6.5.475","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}